Michael Schultz - Concepedia

Author

Michael Schultz

Also Known As

Kristina Aluzaite, M SCHULTZ, M Schultz, M. Schultz, MICHAEL SCHULTZ, Michael P. Schultz, Michael Schultz, Schultz, M, Schultz, M., Schultz, Michael

182

Publications

11.3K

Citations

H-Index

Concepts

All Affiliations

University of Otago Dunedin Public Hospital Southern District Health Board University of Regensburg Glasgow Royal Infirmary

About

Michael Schultz is an author at University of Otago specializing in medicine, gastroenterology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	3.1K
2	Health Sciences	4	4	567
3	Public Health	3	3	273
4	Cell Biology	1	1	52
5	Cellular Physiology	1	1	52

Michael Schultz

Publications

10.5K

Citations

H-Index

Page 1

	Year	Citations
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection Eric Lawitz, Alessandra Mangia, David Wyles, New England Journal of Medicine	2013	1.8K
Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice Rance K. Sellon, Susan L. Tonkonogy, Michael Schultz, Infection and Immunity	1998	1.5K
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) Victoria Hall, Sarah Foulkes, André Charlett, The Lancet Long CovidSars-cov-2 Infection RatesCovid-19 PandemicInfection ControlAntibody-negative Health-care Workers	2021	732
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, Journal of Hepatology FibrosisHepatologyLiver PhysiologyClinical TrialsPathology	2020	438
Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study Adrian J. Stanley, Loren Laine, Harry R. Dalton, BMJ	2017	396
Lactobacillus plantarum 299V in the Treatment and Prevention of Spontaneous Colitis in Interleukin-10-Deficient Mice Michael Schultz, Claudia Veltkamp, Levinus A. Dieleman, Inflammatory Bowel Diseases	2002	369
Lactobacillus GG in inducing and maintaining remission of Crohn's disease Michael Schultz, Antje Timmer, Hans Herfarth, BMC Gastroenterology	2004	342
Different Subsets of Enteric Bacteria Induce and Perpetuate Experimental Colitis in Rats and Mice Heiko C. Rath, Michael Schultz, René Freitag, Infection and Immunity	2001	340
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection Miguel Regueiro, Brian G. Feagan, Bin Zou, Gastroenterology	2016	320

Page 1